scispace - formally typeset
T

Tracey R. O’Donovan

Researcher at University College Cork

Publications -  28
Citations -  7302

Tracey R. O’Donovan is an academic researcher from University College Cork. The author has contributed to research in topics: Autophagy & Programmed cell death. The author has an hindex of 15, co-authored 25 publications receiving 5888 citations. Previous affiliations of Tracey R. O’Donovan include National University of Ireland.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics.

Tracey R. O’Donovan, +2 more
- 01 May 2011 - 
TL;DR: Observations suggest that an autophagic response to chemotherapy is a survival mechanism that promotes chemoresistance and recovery and that selective inhibition of autophagy regulators has the potential to improve chemotherapeutic regimes.
Journal ArticleDOI

Curcumin induces apoptosis-independent death in oesophageal cancer cells

G. O’Sullivan-Coyne, +4 more
- 27 Oct 2009 - 
TL;DR: Curcumin can induce cell death by a mechanism that is not reliant on apoptosis induction, and thus represents a promising anticancer agent for prevention and treatment of oesophageal cancer.
Journal ArticleDOI

Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response.

Kheshwant S. Gill, +7 more
- 01 Aug 2016 - 
TL;DR: This review examines the interplay between the glycolysis modulation and the immune response as an anti-cancer therapy and looks at the glyCOlysis pathway as a target for cancer treatments.